[caption id="attachment_21245" align="alignnone" width="632"] W.K. Alfred Yung, M.D., and Waun Ki Hong, M.D., F.A.C.P., D.M.Sc .(Hon.)[/caption] Respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice were recognized this evening as Giants of Cancer Care in an event...
https://youtu.be/S4bAu0i9i4w The National Foundation for Cancer Research’s (NFCR) annual marquee event was held in Washington, DC on Saturday evening, May 5th. The 2018 Szent-Györgyi Prize for Progress in Cancer Research ceremony and dinner occasioned much, including a gathering of NFCR principals and scientists, communication of the...
FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations ROCKVILLE, MD – A trio of papers co-authored by four National...
In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes, “how different molecular subtypes of...
Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is...
[vc_row][vc_column][vc_single_image image="20545" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]In recognition of Esophageal Cancer Awareness Month, recognized in April, the National Foundation for Cancer Research offers a look at a significant diagnostic advancement for a risk factor associated with the terrible disease. A new test for Barrett’s esophagus, a precancerous...
[vc_row][vc_column][vc_column_text css=""] Led by Dr. Gunnel Halldén of Queen Mary University in London, a team of scientists modified a common flu virus to successfully inhibit the growth of pancreatic cancer. The new technique could potentially become a promising new treatment for patients with the aggressive disease,...
President Bill Clinton declared March Colorectal Cancer Awareness Month in 2000, highlighting a disease that represents eight percent of all new cancers diagnosed yearly and, out of the estimated 135,430 people who developed it just last year, caused an estimated 50,260 deaths in the United...
Multiple myeloma (MM) is a bone marrow cancer that affects plasma cells. Bone marrow is the soft and spongy tissue which resides in the cavities of many of our bones. It is rich in cells which produce new blood cells....
Search NFCR
Popular searches
